Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 158 | 940 | 12,899 | 824 | 900,701 |
| Gross Profit | 158 | 940 | 12,899 | 824 | 900,701 |
| Operating Expenses | 183,418 | 176,912 | 158,597 | 129,673 | 138,083 |
| Operating Income | -183,260 | -175,972 | -145,698 | -128,849 | 762,618 |
| Other Income | 3,544 | 363 | 2,197 | 1,101 | 750 |
| Pre-tax Income | -179,716 | -175,609 | -143,501 | -127,748 | 763,368 |
| Income Tax | 6,118 | 3,608 | -2,253 | -595 | 4,143 |
| Net Income Continuous | -185,834 | -179,217 | -141,248 | -127,153 | 759,225 |
| Net Income | $-185,834 | $-179,217 | $-141,248 | $-127,153 | $759,225 |
| EPS Basic Total Ops | -2.40 | -2.32 | -1.86 | -1.67 | 10.01 |
| EPS Basic Continuous Ops | -2.40 | -2.32 | -1.29 | -1.67 | 9.44 |
| EPS Diluted Total Ops | -2.40 | -2.32 | -1.56 | -1.67 | 9.44 |
| EPS Diluted Continuous Ops | -2.40 | -2.32 | -1.56 | -1.67 | 9.44 |
| EBITDA(a) | $-175,991 | $-169,933 | $-139,437 | $-123,525 | $766,271 |